Kim, H. K., Kang, J. W., Park, Y., Kim, J. Y., Kim, M., Kim, S. J., . . . Park, J. (2020). Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors. Pharmacol Res Perspect.
Citação norma ChicagoKim, Hark Kyun, et al. "Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients With Refractory Solid Tumors." Pharmacol Res Perspect 2020.
Citação norma MLAKim, Hark Kyun, et al. "Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients With Refractory Solid Tumors." Pharmacol Res Perspect 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.